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Neonatal Outcome in Preterm InfantsTo the Editor,
Some readers were confused by about the data in Table 2 in
our article, and they wanted us to explain the discrepancy
that the incidence of respiratory distress syndrome (RDS)
and the use of mechanical ventilation was significantly
lower in infants in the MIRþFIR group or MIRþFIRþ group
than in infants in the MIR-FIR- group, but the incidence of
pulmonary surfactant (PS) administration was similar among
the three groups. In our preterm newborns, the PS admin-
istration was used not only for RDS treatment, but also for
prophylactic therapy. Therefore, some cases in each group
that received PS administration were not RDS patients. We
think that this is the main reason for the discrepancy.
It is widely accepted that bronchopulmonary dysplasia
(BPD) is a consequence of lung inflammation that is caused
by intrauterine infection and/or postnatal inflammation. A
meta-analysis of clinical studies showed that chorioamnio-
nitis was significantly associated with BPD.1 However, we
were unable to confirm the association between placental
inflammation and bronchopulmonary dysplasia (BPD) from
our clinical data analysis. Low gestational age is a very
important risk factor for BPD, and the incidence of BPD
significantly decreases with the increase in gestational age.
We therefore suggested that one of possible explanation is
that the patient population of our study was relatively
older, although other variable factors cannot be excluded.
The relationship between intrauterine inflammation and
BPD is very complicated. Postnatal inflammation also plays
an important role. A clinical study has shown that pro-
longed mechanical ventilation or postnatal infection in-
teracts with antenatal infection to further increase the risk
of chronic lung disease in preterm neonates.2 PS compo-
nents can decrease harmful lung inflammatory responses,
and animal-derived PS extract is associated with a
decreased risk of BPD.3 Therefore, PS is widely used as a
prophylactic therapy for our preterm newborns, which mayDOI of original article: http://dx.doi.org/10.1016/
j.pedneo.2013.08.007.
1875-9572/$36 Copyright ª 2013, Taiwan Pediatric Association. Publish
http://dx.doi.org/10.1016/j.pedneo.2013.08.006also mitigate the effect of placental inflammation on the
development of BPD. More studies are needed to clarify the
relationship between placental inflammations, postnatal
inflammation, medical intervention, and BPD.
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